To validate these results in another patient cohort and at the protein level, we characterized the expression of MISP in a series of 286 GC cases from all stages and categorized the expression in two groups, high and low (includes negative cases), as described in the Material and Methods Section. The gene discussed is MISP; the disease is gastric cancer.